VBI Vaccines Inc. 45,454,545 Common Shares (no par value per share) Underwriting AgreementVBI Vaccines Inc/Bc • April 24th, 2020 • Pharmaceutical preparations • New York
VBI Vaccines Inc., a company incorporated under the Business Corporations Act (British Columbia) (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 45,454,545 common shares, no par value per share (the “Shares”). The 45,454,545 Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 6,818,181 Shares as provided in Section 2. The additional 6,818,181 Shares that may be sold by the Company pursuant to such option are collectively called the “Optional Shares.” The Firm Shares and, if and to the extent such option is exercised, the Optional Shares, are collectively called the “Offered Shares.” Raymond James & Associates, Inc. (“Raymond James”) and Oppenheimer and Co. Inc. (“Oppenheimer”) have agreed to act as representatives of the several Underwriters (in such capacity, the “Representatives”) in connection
